Back to companies

Twist Bioscience Corp: Overview

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Twist Bioscience Corp (Twist Bioscience) is a synthetic biology company that develops a disruptive deoxyribonucleic acid (DNA) synthesis platform. The company's products include genes, oligo pools, next-generation sequencing (NGS) products, variant libraries, synthetic controls products, antibody discovery products, in vitro diagnostic regulation (IVDR) compliant products, among others. Twist Bioscience products are used in applications such as cancer research, deoxyribonucleic acid (DNA) data storage, drug discovery, and infectious diseases. The company serves the healthcare, industrial chemicals, agriculture and academic research sectors. It operates in Israel, the US, Europe, Singapore, and China. Twist Bioscience is headquartered in South San Francisco, California, the US.

Gain a 360-degree view of Twist Bioscience Corp and make more informed decisions for your business Gain a 360-degree view of Twist Bioscience Corp and make more informed decisions for your business Register your interest
Headquarters United States of America

Address 681 Gateway Boulevard, South San Francisco, California, 94080


Telephone 1 800 7190671

No of Employees 979

Industry Pharmaceuticals and Healthcare

Ticker Symbol & Exchange TWST (NASD)

Revenue (2024) $376.6M 20.3% (2024 vs 2023)

EPS XYZ

Net Income (2024) XYZ 62.8% (2024 vs 2023)

Market Cap* $5.8B

Net Profit Margin (2024) XYZ 69.1% (2024 vs 2023)

* As of and is in US$
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Register your interest

Twist Bioscience Corp premium industry data and analytics

40+

Pipeline Drugs

Identify which of Twist Bioscience Corp’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

1

Clinical Trials

Determine Twist Bioscience Corp go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

1

Catalyst Calendar

Proactively evaluate Twist Bioscience Corp’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

1

ICT Spend & Tech Priorities

IT Client Prospector provides intelligence on Twist Bioscience Corp’s likely spend across technology areas enabling you to understand the digital strategy.

Products and Services

Products Brands
Genes: FlexPrep
Multiplexed Gene Fragments
Express Genes
XYZ
XYZ
XYZ
Understand Twist Bioscience Corp portfolio and identify potential areas for collaboration Understand Twist Bioscience Corp portfolio and identify potential areas for collaboration Register your interest

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2025 New Products/Services In December, the company introduced Plasmid DNA Preps.
2025 Contracts/Agreements In October, the company expanded collaboration with Element Biosciences to launch the Trinity Freestyle Fast Hybridization workflow for AVITI sequencers.
2025 Contracts/Agreements In September, the company entered into a partnership with Synthetic Design Lab to develop novel antibody-drug conjugates for various cancer types.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Register your interest
Image for loader

Competitor Comparison

Key Parameters Twist Bioscience Corp Thermo Fisher Scientific Inc Agilent Technologies Inc Illumina Inc GenScript Biotech Corp
Headquarters United States of America United States of America United States of America United States of America China
City South San Francisco Waltham Santa Clara San Diego Nanjing
State/Province California Massachusetts California California Jiangsu
No. of Employees 979 125,000 17,900 8,600 6,165
Entity Type Public Public Public Public Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Register your interest
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Register your interest
Executives
Name Position Board Since Age
Emily M. Leproust, Ph.D. Chairman; Chief Executive Officer Executive Board 2013 52
Adam Laponis Chief Financial Officer Senior Management 2024 48
Patrick Finn, Ph.D Chief Operating Officer; President Senior Management 2022 53
Robert Werner Chief Accounting Officer Senior Management 2023 51
Mike Fero Chief Information Officer Senior Management - -
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Gain insight into Twist Bioscience Corp key executives to enhance your sales strategy Gain insight into Twist Bioscience Corp key executives to enhance your sales strategy Register your interest
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Why are you leaving?